INJECTAFER - Iron supplement that helps replete the bodies iron stores that have inadequate response to oral iron supplement in iron deficient patients.

VENOFER - Iron supplement that helps replete the bodies iron stores that have inadequate response to oral iron supplement in iron deficient patients.

REMICADE (INFLIXIMAB) - Biologic therapy for moderate to severe Crohn’s disease or ulcerative colitis.

RENFLEXIS - Biosimilar therapy for moderate to severe Crohn’s disease or ulcerative colitis. Biosimilar therapy is product that is deemed highly similar to an already approved biologic (Remicade/Infliximab).  These products are confirmed through various tests and clinical research.

INFLECTRA -  Biosimilar therapy for moderate to severe Crohn’s disease or ulcerative colitis. Biosimilar therapy is product that is deemed highly similar to an already approved biologic (Remicade/Infliximab).  These products are confirmed through various tests and clinical research.

ENYTVIO (VEDOLIZUMAB) - A newer biologic therapy for adults with moderate to severe Crohn’s disease or ulcerative colitis who have had inadequate response to conventional therapy.

STELARA (USTEKINUMAB) - Biologic therapy for treatment of moderate to severe Crohn’s disease.